Engagement
We invited engagement with us, sharing the knowledge we have and listening to learn what we don’t.
Idea Generation Workshops: Fostering collaboration for vital new research
Launched in 2019, our annual Idea Generation Workshop enables us to deliver on our strategic goals to accelerate the pace of discovery and foster collaboration between researchers.
These workshops help drive our research pipeline and provide a valuable platform for members to connect and develop new ideas using a collaborative and multidisciplinary approach.
Our most recent event occurred in May 2023, and workshopped five new ideas for late-stage colorectal cancer - a focus area in line with our research priorities. Ideas that progress past the Workshop are then developed further in the newly-formed concept development groups, before being presented to the Lower GI Working Party.
Congratulations to Dr Mark Nalder (REAL-CRC), Dr Alex Flynn (PREDICT 5FU-mCRC), and Professor Vicki Whitehall – all of whom have elected to progress their embryonic ideas through the AGITG Research Development and Prioritisation Framework.
Thank you to our Co-Convenors Associate Professor Cherry Koh and Dr Sina Vatandoust for helping to host another successful workshop.
The 2021 AGITG-Pancare #IGW Grant winner, ACME ABC, opened at @MonashHealth - presenting a new option for patients with this #RareCancer.
More about the trial: http://gicancer.org.au/ACME-ABC
(3/6)
@PancareAus #GIcancer #BiliaryTract #translational
By speaking at the IGW, Prof John Mariadason hopes to find clinicians who have/plan to run trials involving radiation therapy in #GIcancers in which the concept can be tested. #IGW
AGITG Preceptorship Program: Encouraging the next generation of research leaders
AGITG Preceptorships are premiere educational events for senior trainees and Junior faculty, which explore historical, current, and emerging treatments for the management of GI cancers.
Since launching our Preceptorship Program in 2013, these events have evolved to become a pivotal way to deliver on our strategic objective to encourage and support emerging research leaders.
The 2023 Preceptorship explored the current management of Biliary Tract Cancer and Hepatocellular Carcinoma. Expert preceptors representing the disciplines of surgery, gastroenterology, radiation oncology and medical oncology were in attendance, offering
invaluable discussions, insights, and mentorship. The background of the preceptees was just as diverse, with colleagues from Aotearoa New Zealand and the UK in attendance, as well as attendees from all over Australia.
Thank you to AstraZeneca for your sponsorship of this wonderful event.
25th Annual Scientific Meeting: A celebration of members and research
The 25th AGITG Annual Scientific Meeting (ASM) was held for the first time in Aotearoa New Zealand and was attended by over 350 delegates from various oncology-focused disciplines, as well as community and industry.
The 2023 ASM theme was ‘Navigating Pathways to Equity in GI Cancer Research’. The topical theme stressed the need to extend access and increase equity in therapeutic options – whether that was across regional, rural and remote areas, or across culturally diverse and First Nations populations.
The Meeting’s Opening Plenary featured distinguished surgeon Professor Jonathan Koea (Ngāti mutunga, Ngāti tama) and renowned Indigenous health leader Professor Lisa Jackson Pulver AM on the continued impact of colonisation on a patient’s cancer journey, including access to cancer care. For our Closing Plenary, we welcomed a series of talks from Professor George Laking, Claire Howlett, Dr Kimi Hēnare, Professor Cheri Ostroff and Associate Professor Craig Underhill on equity-focussed cancer care.
To bring the Meeting’s focus on equity to a full circle, each speaker also issued a subsequent challenge for the AGITG to meet in coming years.
The range of research showcased at the Meeting came through in the number of Best of Posters presentations, which had increased this year, and especially in the popular New Concepts Symposium – where members presented concepts at an early stage of development and received feedback from the delegates and invited international faculty.
Thank you to the Meeting Organising Committees, sponsors, Chairs, presenters, and delegates for being a part of one of our most successful meetings yet.
Listen to The Oncology Podcast‘s wrap-up episode, featuring Co-Convenor Dr Ben Lawrence and International Invited Faculty A/Prof Katherine Garman
Our annual awards
AGITG offers many annual awards to recognise the outstanding efforts of members, and to award research concepts that have the potential for positive impact across GI cancer research.
John Zalcberg AO Award
For Excellence in AGITG Research
Associate Professor Haryana Dhillon
Our flagship award was presented to A/Prof Dhillon in recognition of her significant and outstanding leadership in AGITG research over a sustained period. A/Prof Dhillon joined the AGITG in 1996 and is a leading figure in the Psycho-oncology Co-operative Research Group (PoCoG). She is currently Co-Chair of our OXTOX trial and was Principal Investigator of CHALLENGE, an AGITG endorsed study.
Member Fundraiser of the Year
A/Prof Andrew Dean
in recognition of Chris Reichstein
Outstanding Metropolitan Site
St John of God Subiaco Hospital, WA
Outstanding Regional, Rural and Remote Site
Illawarra Shoalhaven Local Health District Cancer Centre, NSW
Early Career Researcher Award
Dr Dmitrii Shek
Christine Aiken Memorial Award
Kate Hunter
Best New Concept
Supported by AstraZeneca
Dr Alex Flynn
Runner-Up, Best New Concept
Supported by AstraZeneca
A/Prof Andrew Dean & Prof Tim Price
Best Poster
Supported by Amgen
Dr Avraham Travers
Runner-Up, Best Poster
Supported by Amgen
Dr Natalia Vukelic
2023 Innovation Grant
We are grateful to be able to provide members with exclusive funding opportunities for new research, thanks to the generosity of our GI cancer community. Over $1.9 million in grants has supported 14 new research projects from AGITG members since 2015.
The 2023 Innovation Grant was presented to Dr David Liu for his research concept titled, “Multi-omics evaluation of peritoneal fluid in gastro-oesophageal cancer: A prospective trial to develop a sensitive assay to detect clinically occult peritoneal metastases (OMEGCA)”.
“We hope that our findings will inform patient counselling, treatment decision-making and design of future therapeutic clinical trials.”
Merck–AGITG Clinical Research Fellowship
At the ASM, Dr Julia Freckelton was awarded the 2024 Merck–AGITG Clinical Research Fellowship. As the recipient of the fellowship, she will be spending one year at the Royal Marsden Hospital in London, UK, known to be the busiest GI cancer clinic in the country.
“My interest in GI oncology began when I did a PhD in pancreatic cancer and outcomes for patients with the disease. I certainly hope to come back with some more skills and knowledge as a clinician oncologist, but also to develop new skills in research and continue to participate in research – both domestically but also overseas. Thank you to Merck and AGITG for giving me this opportunity.”
Thank you to the sponsors of the 2023 Annual Scientific Meeting.
Platinum sponsor
Gold sponsor
Silver sponsor
Bronze sponsor
Launching our EDI statement: Creating more equitable research for Australians with GI cancer
In 2023, we underwent a consultation process to create and publish an Equity, Diversity and Inclusion Statement. Our statement acknowledges the need for continual and sustained effort to understand and address the factors that contribute to disparities in outcomes for people with GI cancers in Australia and Aotearoa New Zealand.